← Leaderboards
Ryan Ungaro
Icahn School Of Medicine At Mount Sinai
$1,196,705
Attributed
$1,196,705
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $316.1K · FY2019–24$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,196,705 · 2
By mechanism
K23$948,275 · 1
R03$248,430 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Ruth Jf Loos$12,913,461
- Amy R. Kontorovich$4,545,755
- Christina M Wyatt$11,078,328
- Fred Chau-Yang Ko$1,674,114
- Michael David Linderman$503,494
Others in their field
Other Emerging Leaders on “S Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$249,760,384
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$220,039,059
- Kimberly Smith · Ppd Development Lp$115,671,664
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Research focus
S DiseaseLarge Bowel Crohn&AposAwardGrantIntestinal FistulaIntestinesCohortDiagnosisFailureGene ExpressionInflammationInflammatoryAreaChildDisease ProgressionBiopsyBloodCrohn&AposBlood ProteinsBiologicalBiological MarkersGastrointestinal Tract StructureChronicImmunogenetics
Grant awards (7)
Blood Protein Markers of Biologic Treatment Response in Crohn's Disease$121,680
R03 · FY2024 · DK · contact PI
Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns Disease$189,342
K23 · FY2023 · DK · contact PI
Blood Protein Markers of Biologic Treatment Response in Crohn's Disease$126,750
R03 · FY2023 · DK · contact PI
Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns Disease$189,342
K23 · FY2022 · DK · contact PI
Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns Disease$189,342
K23 · FY2021 · DK · contact PI
Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns Disease$189,342
K23 · FY2020 · DK · contact PI
Assessing Predictors of Response to Anti-Tumor Necrosis Alpha Therapy in Early Crohns Disease$190,907
K23 · FY2019 · DK · contact PI